XTL Biopharmaceuticals Ltd. Share Price TEL AVIV STOCK EXCHANGE
Equities
XTLB
IL0010854979
Biotechnology & Medical Research
Sales 2021 | - | Sales 2022 | - | Capitalization | 6.36M 23.87M 506M |
---|---|---|---|---|---|
Net income 2021 | - 0 0 | Net income 2022 | -1M -3.75M -79.59M | EV / Sales 2021 | - |
Net cash position 2021 | 6.13M 22.99M 488M | Net cash position 2022 | 3.72M 13.96M 296M | EV / Sales 2022 | - |
P/E ratio 2021 |
39.2
x | P/E ratio 2022 |
-4.72
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 93.3% |
Managers | Title | Age | Since |
---|---|---|---|
Shlomo Shalev
CEO | Chief Executive Officer | 62 | 29/12/14 |
Itay Weinstein
DFI | Director of Finance/CFO | 52 | 31/12/98 |
Doron Turgeman
CHM | Chairman | 56 | 29/12/14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Shlomo Shalev
CEO | Chief Executive Officer | 62 | 29/12/14 |
Director/Board Member | 56 | 28/01/20 | |
Director/Board Member | 53 | 31/03/17 |
1st Jan change | Capi. | |
---|---|---|
+1.77% | 42.75B | |
+47.70% | 41.61B | |
+12.24% | 41.34B | |
-8.83% | 26.59B | |
+7.44% | 25.49B | |
-23.01% | 18.12B | |
+30.56% | 12.24B | |
-1.82% | 11.76B | |
+8.35% | 11B |